Core Viewpoint - Beijing Health (02389.HK) has entered into a supplemental agreement to amend certain terms of the shareholders' agreement and established a concerted action agreement with Jinfu regarding the target company, 1121695 B.C. Ltd, which will lead to the target company becoming a subsidiary of Beijing Health [1][2]. Group 1 - The concerted action agreement allows Beijing Health and Jinfu to act in unison at the target company's shareholder meetings, controlling approximately 78.15% of the equity interests [2][4]. - The target company's board will consist of three directors, with Beijing Health entitled to nominate two, thereby controlling the majority of the board [2][3]. - Following the amendments and agreements, the target company will be classified as a majority-controlled subsidiary, and its financial performance will be consolidated into Beijing Health's financial statements [2][4]. Group 2 - The target company is registered under British Columbia law and is primarily engaged in property holding, with its main asset being Royal Towers, a mixed-use complex that includes 135 residential units and approximately 20,848 square feet of commercial space [3][4]. - Beijing Health currently holds a 47.47% stake in the target company and has provided multiple rounds of financial support for its operations [4]. - The day-to-day operations and strategic planning of the target company are overseen by personnel appointed by Beijing Health, enhancing operational control and efficiency [4].